Clinical Trial Update: Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients

View source ↗

Summary

Long-term follow-up results are reported for sub-retinal transplantation of human embryonic stem cell-derived retinal pigment epithelium cells in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stargardt Disease

Drugs mentioned

• hESC-derived RPE cells (human embryonic stem cell-derived retinal pigment epithelium cells)

Snippet

Sponsor: Astellas Institute for Regenerative Medicine | Conditions: Stargardt's Macular Dystrophy | Status: COMPLETED